BrainsWay Ltd (BRSYF) (Q3 2026) Earnings Call Highlights: Revenue Jumps 34% as Margins Expand ...
What Brainsway (BWAY) Said on Its Q3 Earnings Call
BrainsWay Reports Third Quarter 2026 Financial Results and Operational Highlights
BrainsWay Ltd. (BWAY) Q3 2026 Earnings Call Transcript
BrainsWay Q3 2026 Earnings Call Transcript
BrainsWay Raises FY2026 Sales Guidance from $68.000M-$70.000M to $70.000M vs $69.283M Est
BrainsWay Q3 EPS $0.05 Misses $0.09 Estimate, Sales $18.146M Beat $17.891M Estimate
BrainsWay Announces Strategic Collaboration with Mindful Health Solutions
BrainsWay Partners With Mindful Health Solutions To Pursue Strategic Initiatives To Expand Patient Access To Health Treatments
BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives
BrainsWay Announces Strategic Collaboration with Inland Psychiatry Medical Group
HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $19 Price Target
BrainsWay, Inland Psychiatric Collaborate On Multi-System Deep TMS Deployment And Mental Health Research Initiatives
BrainsWay Reports Rise in Favorable Accelerated Deep TMS™ Coverage to Over 70 Million Covered Lives
BrainsWay: Execution Isn't The Problem, Market Size Is
BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
BTIG Reiterates Buy on BrainsWay, Maintains $20 Price Target
Are Options Traders Betting on a Big Move in Brainsway Stock?
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.